Papers
1
Total Citations
17
H-Index
1
About
Dr. Qiwen Yang is a leading clinical microbiologist whose work focuses on accelerating antimicrobial susceptibility testing (AST) to combat the growing threat of multidrug-resistant pathogens. Her key research areas include rapid diagnostic methodologies, sepsis management, and the optimization of antibiotic therapy. Dr. Yang’s major contribution is the development of CAST‑R, an automated system for rapid, reliable AST directly from positive blood cultures. Her landmark 2022 paper on this method, which has garnered 17 citations, demonstrates how CAST‑R can dramatically reduce turnaround times for critical drugs like tigecycline, enabling clinicians to tailor treatments for septic patients within hours rather than days. This innovation directly addresses the instability and labor-intensity of conventional AST, offering a scalable solution for hospital laboratories. By bridging the gap between rapid detection and actionable susceptibility data, Dr. Yang’s work is pivotal in the fight against antimicrobial resistance, empowering precision medicine at the bedside. Her research continues to shape the future of infectious disease diagnostics, making her a vital voice in clinical microbiology.
Research Focus
Key Achievements
Top Papers
- 1